Abner Antonio Murray, Hematology/Oncology Fellow at UNC School of Medicine, shared a post on X:
“Honored to be selected for my first FDA/ASCO Fellows’ Workshop—and thrilled to experience it in person after years of virtual sessions.
We explored:
- FDA’s role in oncology drug development
- Case studies: inavolisib and ponatinib
- Breakouts + career insights from FDA Oncology leaders
Grateful to Tatiana Prowell, her team, and the ASCO staff for organizing such an impactful program. Special bonus: connecting with
fellow ASCO TECAG members Antonio Ocejo and Fionnuala Crowley outside of the Annual Meeting.”